RxDoctor Payments Data

Jonathan Divine, DO

Family Medicine · Jacksonville, FLNPI 1710173968

Payments from drug & device makers

$464in general payments, 2019–2025

Across 28 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$132
  • Novo Nordisk$74
  • Takeda Pharmaceuticals U.S.A., Inc.$60
  • Medtronic$54
  • GSK$50
  • Amgen$42
  • plus $52 from 2 others

What the payments were for

  • Food & beverage$45899%
  • Education$61%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$464 in reported general payments places this provider in the 50th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$115,603
Medicare patients
247
Services billed
1,417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide84$115,175
TrulicityDulaglutide42$56,895
MounjaroTirzepatide48$56,836
EliquisApixaban67$55,848
JardianceEmpagliflozin43$52,346
FarxigaDapagliflozin Propanediol30$37,250
JanuviaSitagliptin Phosphate18$21,125
Breo ElliptaFluticasone/Vilanterol28$18,691
Tresiba Flextouch U-100Insulin Degludec13$17,632
TradjentaLinagliptin11$15,642
GlyxambiEmpagliflozin/Linagliptin13$10,302
JanumetSitagliptin Phos/Metformin Hcl16$8,019
VascepaIcosapent Ethyl14$6,939
SymbicortBudesonide/Formoterol Fumarate17$6,005
Combivent RespimatIpratropium/Albuterol Sulfate12$5,779

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$74$115,17584 claims
Lilly USA, LLCTrulicity, Mounjaro$25$113,73190 claims
AstraZenecaFarxiga, Symbicort$132$43,25547 claims
GSKBreo Ellipta$50$18,69128 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →